A detailed history of Patient Square Capital LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Patient Square Capital LP holds 12,228,465 shares of ROIV stock, worth $143 Million. This represents 59.99% of its overall portfolio holdings.

Number of Shares
12,228,465
Previous 12,228,465 -0.0%
Holding current value
$143 Million
Previous $129 Billion 0.28%
% of portfolio
59.99%
Previous 54.89%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$9.87 - $11.8 $4.06 Million - $4.86 Million
-411,455 Reduced 3.26%
12,228,465 $129 Billion
Q2 2023

Aug 11, 2023

BUY
$7.09 - $10.08 $41.2 Million - $58.6 Million
5,813,953 Added 85.17%
12,639,920 $127 Billion
Q4 2022

Feb 13, 2023

BUY
$3.36 - $7.99 $22.9 Million - $54.5 Million
6,825,967 New
6,825,967 $54.5 Billion

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.23B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Patient Square Capital LP Portfolio

Follow Patient Square Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patient Square Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Patient Square Capital LP with notifications on news.